ArticleJournal of clinical medicine2020

Targeting β2-Adrenergic Receptors Shows Therapeutical Benefits in Clear Cell Renal Cell Carcinoma from Von Hippel-Lindau Disease.

Virginia Albiñana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.